Kadir A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease - Karami_2019_Front.Mol.Neurosci_12_239
Author(s) : Karami A , Eriksdotter M , Kadir A , Almkvist O , Nordberg A , Darreh-Shori T
Ref : Front Mol Neurosci , 12 :239 , 2019
Abstract : Karami_2019_Front.Mol.Neurosci_12_239
ESTHER : Karami_2019_Front.Mol.Neurosci_12_239
PubMedSearch : Karami_2019_Front.Mol.Neurosci_12_239
PubMedID: 31680850

Title : Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device - Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
Author(s) : Eyjolfsdottir H , Eriksdotter M , Linderoth B , Lind G , Juliusson B , Kusk P , Almkvist O , Andreasen N , Blennow K , Ferreira D , Westman E , Nennesmo I , Karami A , Darreh-Shori T , Kadir A , Nordberg A , Sundstrom E , Wahlund LO , Wall A , Wiberg M , Winblad B , Seiger A , Wahlberg L , Almqvist P
Ref : Alzheimers Res Ther , 8 :30 , 2016
Abstract : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
ESTHER : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
PubMedSearch : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
PubMedID: 27389402

Title : Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease - Karami_2015_Alzheimers.Dement_11_1316
Author(s) : Karami A , Eyjolfsdottir H , Vijayaraghavan S , Lind G , Almqvist P , Kadir A , Linderoth B , Andreasen N , Blennow K , Wall A , Westman E , Ferreira D , Kristoffersen Wiberg M , Wahlund LO , Seiger A , Nordberg A , Wahlberg L , Darreh-Shori T , Eriksdotter M
Ref : Alzheimers Dement , 11 :1316 , 2015
Abstract : Karami_2015_Alzheimers.Dement_11_1316
ESTHER : Karami_2015_Alzheimers.Dement_11_1316
PubMedSearch : Karami_2015_Alzheimers.Dement_11_1316
PubMedID: 25676388

Title : Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease - Kadir_2011_Brain_134_301
Author(s) : Kadir A , Marutle A , Gonzalez D , Scholl M , Almkvist O , Mousavi M , Mustafiz T , Darreh-Shori T , Nennesmo I , Nordberg A
Ref : Brain , 134 :301 , 2011
Abstract : Kadir_2011_Brain_134_301
ESTHER : Kadir_2011_Brain_134_301
PubMedSearch : Kadir_2011_Brain_134_301
PubMedID: 21149866

Title : Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine - Darreh-Shori_2008_Neurobiol.Aging_29_168
Author(s) : Darreh-Shori T , Kadir A , Almkvist O , Grut M , Wall A , Blomquist G , Eriksson B , Langstrom B , Nordberg A
Ref : Neurobiology of Aging , 29 :168 , 2008
Abstract : Darreh-Shori_2008_Neurobiol.Aging_29_168
ESTHER : Darreh-Shori_2008_Neurobiol.Aging_29_168
PubMedSearch : Darreh-Shori_2008_Neurobiol.Aging_29_168
PubMedID: 17196712

Title : PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD - Kadir_2008_Neurobiol.Aging_29_1204
Author(s) : Kadir A , Darreh-Shori T , Almkvist O , Wall A , Grut M , Strandberg B , Ringheim A , Eriksson B , Blomquist G , Langstrom B , Nordberg A
Ref : Neurobiology of Aging , 29 :1204 , 2008
Abstract : Kadir_2008_Neurobiol.Aging_29_1204
ESTHER : Kadir_2008_Neurobiol.Aging_29_1204
PubMedSearch : Kadir_2008_Neurobiol.Aging_29_1204
PubMedID: 17379359

Title : Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET - Kadir_2007_Psychopharmacology.(Berl)_191_1005
Author(s) : Kadir A , Darreh-Shori T , Almkvist O , Wall A , Langstrom B , Nordberg A
Ref : Psychopharmacology (Berl) , 191 :1005 , 2007
Abstract : Kadir_2007_Psychopharmacology.(Berl)_191_1005
ESTHER : Kadir_2007_Psychopharmacology.(Berl)_191_1005
PubMedSearch : Kadir_2007_Psychopharmacology.(Berl)_191_1005
PubMedID: 17310387

Title : Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism - Darreh-Shori_2006_Neurobiol.Dis_24_326
Author(s) : Darreh-Shori T , Brimijoin S , Kadir A , Almkvist O , Nordberg A
Ref : Neurobiol Dis , 24 :326 , 2006
Abstract : Darreh-Shori_2006_Neurobiol.Dis_24_326
ESTHER : Darreh-Shori_2006_Neurobiol.Dis_24_326
PubMedSearch : Darreh-Shori_2006_Neurobiol.Dis_24_326
PubMedID: 16973370